Aurigene Pharmaceutical Services offers a full range of exploratory and GLP toxicology studies supported by clinical and anatomic pathology services, formulation analysis, toxicokinetic analysis, and interpretation and reporting. General toxicology studies range from single-dose and repeat dose toxicology studies, genetic toxicology, and IND and NDA enabling safety toxicology package. We have a track record of successfully filing IND’s using the in-house data with the US FDA, MHRA, EMA and DCGI and ANDAs with US FDA.
The toxicology services team has experienced and qualified scientists with DABTs and DIBTP certified pathologists. Central to our ability to deliver world-class toxicology services to our global clients from our state-of-the-art vivarium for conducting toxicology studies in rodents. Our facility is GLP certified since 2003 and has sufficient capacity to undertake genetic and GLP toxicology studies.
Our labs are access controlled and spread over 18,040 square feet. The rodent animal facility is a double corridor facility with dedicated experimental rooms equipped with Individually Ventilated Cages (IVC). This animal facility is registered under the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), India. Our toxicology facility has been inspected by US FDA and National GLP Compliance Monitoring Authority (NGCMA). Our stringent data management is GLP compliant and periodically backed up and the systems and processes are rigorously monitored by an independent Quality Assurance unit (QAU).
Aurigene Pharmaceutical Services has proven experience to carry out a range of toxicology services to provide seamless integration between discovery and development programs.
Our GLP facility is specialized in the development of bioanalytical methods to support bioavailability and pharmacokinetics studies. The services include:
Our state-of-the-art facility helps us provide a broad-based analysis of a variety of parameters in each of the following categories:
Toxicology studies help drug discovery scientists understand the adverse effects of New Chemical Entities (NCE) when administered to treat a disease. The studies are done on in-vitro assays and in in-vivo animal models to know the toxicity profile.
Good Laboratory Practise (GLP) toxicology studies are conducted under certified regulatory conditions. The studies are carried out based on procedures laid down by OEDC principles.
The purpose of toxicology studies/tests is to know the adverse/harmful effects of New Chemical Entities (NCEs) on the body of the organism on administration. These studies/tests help drug discovery scientists to design drugs.
Toxicology tests require a lot of time for chronic toxicity tests (6 to 12 months), other studies such as sub-acute (14 to 28 days), sub-chronic (90 days) require less time when compared to chronic toxicity tests.
Mice, rats, guinea pigs, hamsters, rabbits, dogs, monkeys, and minipigs are commonly used in in-vivo toxicity testing.
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.